News
In April 2025, Radiopharm dosed the first patient in the U.S. Phase 2b imaging study of 18F-RAD101. The multicenter, open-label, single arm Phase 2b clinical trial is evaluating the diagnostic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback